Low-dose intravenous immunoglobulin therapy for intractable dermatomyositis skin lesions

Journal of Dermatology

Volumn 26, Issue 7, 1999, Pages 457-459

  Sadayama, Takahiro ^a   Miyagawa, Sachiko ^a   Shirai, Toshihiko ^a  

^a NARA MEDICAL UNIVERSITY   (Japan)

Author keywords

Dermatomyositis; Intravenous immunoglobulin

Indexed keywords

IMMUNOGLOBULIN; IMMUNOGLOBULIN G;

ADULT; ARTICLE; CASE REPORT; DERMATOMYOSITIS; DOSE RESPONSE; DRUG EFFECT; DRUG MEGADOSE; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HUMAN; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; INTRAVENOUS DRUG ADMINISTRATION; MUSCLE WEAKNESS; RASH; SKIN DISEASE; SKIN MANIFESTATION;

EID: 0032772612     PISSN: 03852407     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1346-8138.1999.tb02026.x     Document Type: Article

References (16)

1. Krain LD: Dermatomyositis in six patients without initial muscle involvement, Arch Dermatol, 111: 241-245, 1975.
2. Rockerbie NR, Woo TY, Callen JP, Giustina T: Cutaneous changes of dermatomyositis precede muscle weakness, J Am Acad Dermatol, 20: 629-632, 1989.
3. Euwer RL, Sontheimer RD: Amyopathic dermatomyositis (dermatomyositis siné myositis), J Am Acad Dermatol, 24: 959-966, 1991.
4. Stonecipher MR, Jorizzo JL, White WL, Walker FO, Prichard E: Cutaneous changes of dermatomyositis in patients with normal muscle enzymes: Dermatomyositis sine myositis?, J Am Acad Dermatol, 28: 951-956, 1993.
5. Cherin P, Herson S, Wechsler B, et al: Intravenous immunoglobulin for polymyositis and dermatomyositis, Lancet, 336: 116, 1990.
6. Cherin P, Herson S, Wechsler B, et al: Efficacy of intravenous gammaglobulin therapy in chronic refractory polymyositis and dermatomyositis: An open study with 20 adult patients, Am J Med, 91: 162-168, 1991.
7. Lang BA, Laxer RM, Murphy G, Silverman ED, Roifman CM: Treatment of dermatomyositis with intravenous gammaglobulin, Am J Med, 91: 169-172, 1991.
8. Dalakas MC, Ilia I, Dambrosia JM, et al: A controlled trial of high-dose intravenous immune globulin infusions as treatment for dermatomyositis, N Engl J Med, 329: 1993-2000, 1993.
9. Collet E, Dalac S, Maerens B, Courtois JM, Izac M, Lambert D: Juvenile dermatomyositis: Treatment with intravenous gammaglobulin, Br J Dermatol, 130: 231-234, 1994.
10. Cherin P, Piette JC, Wechsler B, et al: Intravenous gamma globulin as first line therapy in polymyositis and dermatomyositis: An open study in 11 adult patients, J Rheumatol, 21: 1092-1097, 1994.
11. Sabroe RA, Wallington TB, Kennedy CTC: Dermatomyositis treated with high-dose intravenous immunoglobulins and associated with panniculitis, Clin Exp Dermatol, 20: 164-167, 1995.
12. Saadeh C, Bridges W, Burwick F: Dermatomyositis: Remission induced with combined oral cyclosporine and high-dose intravenous immunoglobulin, South Med J, 88: 866-870, 1995.
13. Kikuchi-Numagami K, Sato M, Tagami H: Successful treatment of a therapy-resistant severely pruritic skin eruption of malignancy-associated dermatomyositis with high-dose intravenous immunoglobulin, JDermatol, 23: 340-343, 1996.
14. Jolles S, Hughes J, Whittaker S: Dermatological uses of high-dose intravenous immunoglobulin, Arch Dermatol, 134: 80-86, 1998.
15. Bohan A, Peter JB, Bowman RL, Pearson CM: A computer-assisted analysis of 153 patients with polymyositis and dermatomyositis, Medicine, 56: 155-186, 1977.
16. Prasad NKA, Papoff G, Zeuner A, et al: Therapeutic preparations of normal polyspecific IgG (IVIg) induce apoptosis in human lymphocytes and monocytes: A novel mechanism of action of IVIg involving the Fas apoptotic pathway, J Immunol, 161: 3781-3790, 1998.